Home » Topics » Science » New compound

New compound
RSS

VRN-071961: a potent EGFR kinase inhibitor active in Ex20Ins EGFR mutation-driven NSCLC

Nov. 5, 2019

KYM-003, potent and selective STAT3 degrader with strong antitumor activity in vivo

Nov. 5, 2019

Development of novel PRKACA inhibitors for the treatment of fibrolamellar carcinoma

Nov. 5, 2019

RP-7214: a novel DHODH inhibitor with oral activity in preclinical AML models

Nov. 4, 2019

BGS-2019: a new GMPS inhibitor for the treatment of lupus nephritis

Nov. 4, 2019

NTS2-selective compounds with promising activity in preclinical models of pain

Nov. 4, 2019

Preclinical evaluation of highly potent caspase-cleavable docetaxel prodrug, MPD-03

Oct. 31, 2019

New compounds block Tat binding to human DAT for HAND treatment

Oct. 31, 2019

Novel class I HDAC inhibitor R8 demonstrates efficacy both in vitro and in vivo

Oct. 28, 2019

Preclinical results presented of a gene therapy for the treatment of retinitis pigmentosa

Oct. 28, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...